July 28, 2009
Animal health conglomerates reorganise
Merck and Schering are forced to divest some overlapping assets in the animal health sector to win regulatory approval for their US$41 billion merger.
According to Reuters, the companies are asking for bids for both Schering Intervet business and Merck stake in Merial.
It makes more sense for Merck to sell its Merial business, which it co-owns with Sanofi, than the sprawling Intervet business, said unidentified sources.
